(Q54775737)

English

Use of Genetic Testing and Prophylactic Mastectomy and Oophorectomy in Women With Breast or Ovarian Cancer From Families With a BRCA1 or BRCA2 Mutation

scientific article published on May 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/12721241

Use of Genetic Testing and Prophylactic Mastectomy and Oophorectomy in Women With Breast or Ovarian Cancer From Families With a BRCA1 or BRCA2 Mutation (English)

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721241

28 December 2023

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721241

28 December 2023

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721241

28 December 2023

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Caroline Seynaeve

4

object named as

Caroline Seynaeve

1 reference

Europe PubMed Central

3 June 2018

Hanne Meijers-Heijboer

1

object named as

Hanne Meijers-Heijboer

1 reference

Europe PubMed Central

3 June 2018

author name string

Marian Menke-Pluymers

3

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/12721241

Astrid Baalbergen

5

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/12721241

Curt Burger

6

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/12721241

Ellen Crepin

7

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/12721241

Bert van Geel

9

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/12721241

Cecile T. M. Brekelmans

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721241

28 December 2023

Ans W. M. van den Ouweland

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721241

28 December 2023

Jan G. M. Klijn

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721241

28 December 2023

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/12721241

full work available at URL

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.09.052

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Journal of Clinical Oncology

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/12721241

21

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/12721241

1675-1681

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/12721241

9

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/12721241

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.

2

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Unusual case of Smith-Lemli-Opitz syndrome "type II"

3

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Cancer risks in BRCA2 mutation carriers

4

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

5

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

6

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status

7

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk

8

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

9

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.

11

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer

12

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

13

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

14

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer

15

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

16

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

17

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

18

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996

19

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations

20

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Gene-Expression Profiles in Hereditary Breast Cancer

21

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features

22

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

The molecular outlook

23

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Gene expression profiling of cancer by use of DNA arrays: how far from the clinic?

24

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

25

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

26

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Breast reconstruction and tissue expansion in irradiated versus not irradiated women after mastectomy

27

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women.

28

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Utilization of BRCA1/2 genetic testing in the clinical setting: report from a single institution

29

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Issues of regret in women with contralateral prophylactic mastectomies.

30

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

31

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

32

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers

33

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition

34

1 reference

10.1200/JCO.2003.09.052

https://api.crossref.org/works/10.1200/JCO.2003.09.052

28 December 2023

Identifiers

10.1200/JCO.2003.09.052

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/12721241

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/12721241

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54775737&oldid=2039406665"